Back to FDA Applications sponsored by MISSION PHARMA

FDA Drug Application 021618 by MISSION PHARMA

Application Number021618
Application Type New Drug Application
Sponsor ApplicantMISSION PHARMA
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/17/2004N8636000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21618ltr.pdf 5/26/2004
AP05/17/2004N8727000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21618_tindamax_lbl.pdf 5/27/2004
AP05/17/2004N10091000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-618_21-681_21-682_Tindamax.cfm 8/30/2004
AP05/21/2007SE116599003   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021618s003ltr.pdf 5/29/2007
AP05/21/2007SE116650003   http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021618s003lbl.pdf 5/29/2007
AP04/1/2016SCM       




Back to FDA Applications sponsored by MISSION PHARMA